Executive Order 14336: Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve

Executive Order 14336 focuses on strengthening America’s pharmaceutical resilience by building a Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). It highlights the need to stockpile key drug components, especially APIs for around 26 critical medicines, to reduce dependence on foreign sources and enhance readiness during health emergencies. The order directs federal agencies to identify vulnerabilities, prepare storage sites, and prioritize domestic manufacturing wherever possible.